Apellis Pharmaceuticals, Inc. (APLS): SCHEDULE 13G/A filed Jun 5, 2026

Form type
SCHEDULE 13G/A
Filing date
Jun 5, 2026
Accession number
0000895421-26-000190
Filer
Apellis Pharmaceuticals, Inc. (CIK 1492422)